Treatment of Platelets Suspended in New PAS III M Solutions
Platelets suspended in T-PAS+, manufactured by Terumo BCT, Inc., and Grifols® PAS III M, manufactured by Grifols, can now be treated with any of the INTERCEPT™ processing sets for platelets. Combined with the prior CE Mark approvals to treat platelets suspended in 100% plasma, InterSol® and SSP+, this approval further broadens the compatibility of the INTERCEPT system with platelet collection practices.
The processing parameters for platelets suspended in T-PAS+ and Grifols® PAS III M are equivalent to the parameters for platelets suspended in InterSol and SSP+. The designs of the Small Volume (SM), Large Volume (LV), and Dual Storage DS) platelet processing sets remain unchanged.